RE:RE:RE:Those in the know.socalbob - do you really think that if the efficacy nos.in this trial are high they are NOT going to go with at least a Phase 1B in more indications - and these are likely to include the heavyweights of GBM and NSCLC - before accepting bids?
You imply that Sherri`s Royalites will be onerous and then ask what they are.There was considerable goodwill here with (from memory) Sherri voluntarily agreeing to extend exclusivity.
We need to compare like with like - this is not an incremental improvement in one indication.It has the potential to be a new paradigmn in the treatment of cancer and if it so proves it will be valued accordingly and not necessarily related to even the most optimistic forecast on this Thread.